Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bob Langer
Biotech
Tissium raises €39M to advance tech with drug delivery uses
The money will fund work to develop polymers in multiple indications and an associated U.S. expansion.
Nick Paul Taylor
Nov 20, 2019 8:42am
Frequency bags $62M to advance Astellas-partnered hearing drug
Jul 23, 2019 8:13am
Langer’s Lyndra Therapeutics bags $55M to advance ‘ultralong-acting’ pill
Jan 29, 2019 7:00am
A safer way to edit genes with CRISPR?
Nov 13, 2017 11:00am
Trevena CMO exit; AMO deal; Kala IPO; AliveCor-Mayo pact—News of Note
Jul 20, 2017 10:03am
Langer’s Kala files for $86M IPO to bring eye drug to market
Jun 26, 2017 6:42am
